GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:541540) » Definitions » Price-to-Tangible-Book

Solara Active Pharma Sciences (BOM:541540) Price-to-Tangible-Book : 3.08 (As of Jun. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Price-to-Tangible-Book?

As of today (2024-06-01), Solara Active Pharma Sciences's share price is ₹417.60. Solara Active Pharma Sciences's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ₹135.69. Hence, Solara Active Pharma Sciences's Price to Tangible Book Ratio of today is 3.08.

The historical rank and industry rank for Solara Active Pharma Sciences's Price-to-Tangible-Book or its related term are showing as below:

BOM:541540' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.09   Med: 2.2   Max: 4.38
Current: 3.08

During the past 8 years, Solara Active Pharma Sciences's highest Price to Tangible Book Ratio was 4.38. The lowest was 1.09. And the median was 2.20.

BOM:541540's Price-to-Tangible-Book is ranked worse than
61.28% of 860 companies
in the Drug Manufacturers industry
Industry Median: 2.325 vs BOM:541540: 3.08

A closely related ratio is called PB Ratio. As of today, Solara Active Pharma Sciences's share price is ₹417.60. Solara Active Pharma Sciences's Book Value per Sharefor the quarter that ended in Mar. 2024 was ₹240.02. Hence, Solara Active Pharma Sciences's P/B Ratio of today is 1.74.


Solara Active Pharma Sciences Price-to-Tangible-Book Historical Data

The historical data trend for Solara Active Pharma Sciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Price-to-Tangible-Book Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Tangible-Book
Get a 7-Day Free Trial 1.89 4.38 2.19 1.09 2.53

Solara Active Pharma Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 - 1.23 - 2.53

Competitive Comparison of Solara Active Pharma Sciences's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's Price-to-Tangible-Book falls into.



Solara Active Pharma Sciences Price-to-Tangible-Book Calculation

Solara Active Pharma Sciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=417.60/135.69
=3.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Solara Active Pharma Sciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences (BOM:541540) Business Description

Traded in Other Exchanges
Address
27. Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences (BOM:541540) Headlines

No Headlines